Navigation Links
Sysmex America to Enable Prolonged Hematology Instrument Uptime for Hagerstown Medical Laboratory With 1,000th SNCS Activation
Date:6/10/2008

MUNDELEIN, Ill., June 10 /PRNewswire/ -- Sysmex America, Inc. (SAI), today announced the 1,000th activation for its Sysmex Network Communications System (SNCS) at Hagerstown Medical Laboratory, Maryland. SNCS is a remote "real- time" monitoring system that continuously collects and tracks instrument performance data from Sysmex analyzers and links them to Sysmex Service and Support. SNCS enables proactive response to potential instrument problems, thereby reducing the number of unscheduled service calls and laboratory down- time, said John Kershaw, President, Sysmex America. SNCS, introduced by SAI in 4th quarter 2006, can be used with the Sysmex(R) XE-Series, XT-Series, XS- Series, SP-Series and HST hematology products. Hagerstown Medical Laboratory is a full-service clinical laboratory serving a four-state area 24-hours daily, seven days weekly.

"Hagerstown Medical Laboratory and Sysmex America share a mutual commitment to quality healthcare. We believe that SNCS complements Sysmex's instrument reliability and will fully give us the confidence we need to provide consistent clinical laboratory results for physicians and their affiliated healthcare institutions in Maryland, Pennsylvania, West Virginia and Virginia," said Kathy Jones, MT, ASCP, Technical Specialist, Hematology, with Hagerstown Medical Laboratory. Currently, Hagerstown Medical Laboratory processes more than 13,000 tests monthly. Hagerstown Medical Laboratory equipment utilizing SNCS includes two Sysmex XE-2100 and two XT-1800 automated hematology analyzers.

"Sysmex hematology analyzers already own a statistically remarkable mean time between equipment failures, ranking the industry's best in performance and reliability. However, we wanted to offer Hagerstown Medical Laboratory, like all our customers, an even greater degree of reliability with SNCS," said Kershaw.

SNCS benefits Sysmex customers by transmitting their instrument performance data on a real-time basis to Sysmex
'/>"/>

SOURCE Sysmex America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Sysmex America Receives FDA Clearance for XE-5000(TM) Hematology Analyzer
2. Sysmex America Awarded Hematology Contract by Amerinet
3. Foods Co Continues Fight to Help End Hunger in America
4. Democratic National Committee McCain Myth Buster: John McCain and Americas Small Businesses
5. 25 Million Americans Are Underinsured
6. SUA Insurance Company Announces Partnership With American Safety Indemnity Company
7. American Red Cross Responds to Floods and Tornadoes in Central United States
8. USC physician Anne L. Peters receives American Diabetes Associations Distinguished Clinician Award
9. AmeriCares Purchases BLU-MED Portable Hospital for China Earthquake Relief
10. Industrial Control Repair Named Honda of America Manufacturings 2007 Supplier of the Year
11. Nursing Home for Sex Offenders Becomes Law, a First in America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... a decision from the Judicial Panel on Multidistrict Litigation (JPML), according to court ... defects research at their website, the Zofran Birth Defects Lawsuit Center. , GlaxoSmithKline, ...
(Date:7/29/2015)... Carolina (PRWEB) , ... July 29, 2015 , ... ... MetLife, Inc ., a global provider of life insurance, annuities, employee benefits and ... Challenge North Carolina inclusive sporting event taking place in Charlotte, North Carolina ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... the first dermatologist in Sarasota to be chosen by the manufacturer to offer ... offers the first injectable, non-invasive way to treat and eliminate double chin fat,” ...
(Date:7/29/2015)... ... July 29, 2015 , ... Nature’s Artisan, a new ... of gourmet flavors. , Nature’s Artisan was founded by Tina Yarandi, who came up ... the UCLA School of Dentistry. Tina was amazed when she learned about the incredible ...
(Date:7/28/2015)... MD (PRWEB) , ... July 28, 2015 , ... Every ... most kids with the disease only experience through movies and television. They go to ... failure of the right side of the heart as it pushes hard to get ...
Breaking Medicine News(10 mins):Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3Health News:Discover a New Take on Oral Care with Nature’s Artisan Gourmet Mouthwashes 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 2Health News:Special Summer Camp Gives Pulmonary Hypertension Patients Experiences Typically Out of Reach for Kids with their Condition 3
... of research and billions of dollars, cancer remains a ... the body,s defenses and medical intervention. Now an Arizona ... "Cancer is not a random bunch of selfish rogue ... stress, honed by a long period of evolution," claims ...
... in the genome are the cause of many diseases. Gene ... copies offers a means of correcting such defects. Now ... University of Munich, and led by Privatdozent Dr. Carsten Rudolph, ... team shows for the first time that chemical modification of ...
... hundreds of proteins produced by the DNA of tumor ... central to a new treatment for the often-fatal childhood ... pediatric clinical trials of a drug that blocks the ... a promising treatment target for high-risk neuroblastoma," said pediatric ...
... 7 (HealthDay News) -- Heart attack patients who are exposed ... have an increased risk of cancer, a new study finds. ... a heart attack between April 1996 and March 2006 and ... heart attack, 77 percent of the patients underwent at least ...
... News) -- In cold weather, older adults are especially vulnerable ... take steps to prevent this potentially deadly condition. Hypothermia ... remains there for an extended length of time. As people ... of exposure to cold, according to the U.S. National Institute ...
... -- The amount of money spent on psychiatric drugs in ... slower rate than in previous years, a new federal government ... psychiatric drugs rose 5.6 percent, compared with an increase of ... Abuse and Mental Health Services Administration. The agency,s analysis ...
Cached Medicine News:Health News:Conceptualizing cancer cells as ancient 'toolkit' 2Health News:Save messengers -- modified mRNAs open up new therapeutic possibilities 2Health News:Protein may be key to new treatment in a childhood cancer 2Health News:Protein may be key to new treatment in a childhood cancer 3Health News:Heart Scans May Raise Cancer Risk, Study Finds 2Health News:Seniors Vulnerable to Hypothermia 2Health News:U.S. Sees Slowdown in Spending on Mental Health 2
(Date:7/28/2015)... July 28, 2015  SeraCare Life Sciences, a ... announced today at the American Association of Clinical ... licensing agreement with the University of California, San ... (T21), Trisomy 18 (T18) and Trisomy 13 (T13) ... creating "patient-like" reference materials for Non-Invasive Prenatal Testing ...
(Date:7/28/2015)... Ala. , July 28, 2015   Vincari ... for surgeons , has just hired John O,Neil ... Business Development. John has over 30 years of diverse ... roles. Mr. O,Neil,s executive healthcare experience coupled with Vincari,s ... active surgeon allows Vincari to address the challenges both ...
(Date:7/28/2015)... 2015 The Canadian International Pharmacy ... Canadian Anti-Fraud Centre (CAFC), continues to aggressively ... CIPA verification seal on illegitimate pharmacy websites.  The ... pharmacy member companies who have maintained a 100% ... than 10 million Americans since 2002. ...
Breaking Medicine Technology:SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 3John O'Neil Joins Vincari as Executive Vice President of Strategy and Business Development 2Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 2Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 3
... RA Signs and Symptoms Compared to Placebo, ... (Nasdaq: TRBN ) today announced preliminary ... double-blind, placebo-controlled, multicenter,clinical trial of its TRU-015 ... indicated that Trubion,s TRU-015 product candidate, at,well-tolerated ...
... Calif., Sept. 10 Peregrine,Pharmaceuticals, Inc. (Nasdaq: ... antibodies for the treatment of cancer and,hepatitis C ... submitted a,clinical protocol with the Drug Controller General ... safety and efficacy trial of bavituximab in combination,with ...
Cached Medicine Technology:Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 2Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 3Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 4Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis 5Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 2Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 3Peregrine Pharmaceuticals Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer 4
Ideal for abdominal, hip, thigh and knee procedures....
Body Suit w/Bra above knee...
Gynecomastia Vest...
Male Compression Vest, Front Closure...
Medicine Products: